Drug Profile
UDM 002555
Alternative Names: UDM-002555Latest Information Update: 26 Sep 2023
Price :
$50
*
At a glance
- Originator Bristol-Myers Squibb
- Class Antithrombins; Small molecules
- Mechanism of Action PAR-4 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Arterial thrombosis